Inventors: Swati Biswas, Balaram Ghosh

The study develops tailor-made, tumor-targeted vitaprotein nanoparticles designed to deliver a combination of lapatinib and letrozole for treating hormone-receptor-amplified advanced metastatic breast cancers. Vitaprotein nanoparticles are engineered to target tumor cells specifically, enhancing the delivery of therapeutic agents directly to cancer sites.